Teva Pharmaceutical Industries

Type
Internal restructuring
Country
World
Region
Location of affected unit(s)
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
5,000 jobs
Number of planned job losses
Job loss
Announcement Date
10 October 2013
Employment effect (start)
1 January 2014
Foreseen end date
31 December 2014

Description

Israel-based Teva Pharmaceutical Industries group is to cut 5,000 jobs worldwide by the end of 2014.

As announced, in December 2013 there will be specific details on where the cost-cutting measures will take place. Currently, the company operates in about 60 countries.

For previously reported restructuring see: Teva-HU2012, Teva-FR2012, Teva-CZ2010, Teva-HU2010, Teva-IE2009, Teva-CZ2009, Teva-EU2009, Teva-PL2009, and Teva-HU2008.

Sources

  • 10 October 2013: Bloomberg
  • 10 October 2013: Financial Times
  • 10 October 2013: Teva (press release)

Citation

Eurofound (2013), Teva Pharmaceutical Industries, Internal restructuring in World, factsheet number 76046, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/76046.